Oblenio Bio News and Activities

Acquisition, funding and merger involving Oblenio Bio.

• Oblenio Bio has just announced a $62 Million fundraising (posted on June 26 2026).

View the org chart displaying its 11 main executives

Most searched biographies at Oblenio Bio

• Samantha Truex, Chief Executive Officer and Director
• Irena Melnikova, Director
• Joe Jimenez, Director

Create your alert
to follow the executive moves at Oblenio Bio.

Oblenio Bio has 2,428 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Eli Lilly has announced the acquisition of AtaiBeckley  (posted on July 17 2026).
• GSK has acquired Nuvalent (posted on July 17 2026).
• Clearside Biomedical has gone out of its bankruptcy protection  (posted on July 15 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Oblenio Bio

Social media about Oblenio Bio

• Oblenio Bio on Wikipedia, Google News & Yahoo Finance
• Oblenio Bio on LinkedIn, X (Twitter) & YouTube